Addex Therapeutics Statistics

Total Valuation

Addex Therapeutics has a market cap or net worth of CHF 7.24 million. The enterprise value is 5.64 million.

Market Cap	7.24M
Enterprise Value	5.64M

Important Dates

The next estimated earnings date is Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Addex Therapeutics has 98.31 million shares outstanding.

Shares Outstanding	98.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.99%
Owned by Institutions (%)	3.97%
Float	34.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.45
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.50
EV / Sales	4.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.72

Financial Position

The company has a current ratio of 0.71

Current Ratio	0.71
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-495.24

Financial Efficiency

Return on equity (ROE) is -809.52% and return on invested capital (ROIC) is -447.02%.

Return on Equity (ROE)	-809.52%
Return on Assets (ROA)	-125.84%
Return on Capital (ROIC)	-447.02%
Revenue Per Employee	59,997
Profits Per Employee	-488,530
Employee Count	23
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.04% in the last 52 weeks. The beta is 1.98, so Addex Therapeutics's price volatility has been higher than the market average.

Beta (5Y)	1.98
52-Week Price Change	-20.04%
50-Day Moving Average	0.06
200-Day Moving Average	0.07
Relative Strength Index (RSI)	57.55
Average Volume (20 Days)	652,472

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Addex Therapeutics had revenue of CHF 1.38 million and -11.24 million in losses. Loss per share was -0.13.

Revenue	1.38M
Gross Profit	-5.55M
Operating Income	-10.70M
Pretax Income	-10.92M
Net Income	-11.24M
EBITDA	-10.68M
EBIT	-10.70M
Loss Per Share	-0.13

Balance Sheet

The company has 1.63 million in cash and 35,185 in debt, giving a net cash position of 1.59 million or 0.02 per share.

Cash & Cash Equivalents	1.63M
Total Debt	35,185
Net Cash	1.59M
Net Cash Per Share	0.02
Equity (Book Value)	-1.37M
Book Value Per Share	-0.01
Working Capital	-1.36M

Cash Flow

In the last 12 months, operating cash flow was -7.83 million and capital expenditures -4,373, giving a free cash flow of -7.83 million.

Operating Cash Flow	-7.83M
Capital Expenditures	-4,373
Free Cash Flow	-7.83M
FCF Per Share	-0.08

Margins

Gross Margin	n/a
Operating Margin	-775.53%
Pretax Margin	-791.44%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-567.54%

Dividends & Yields

Addex Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-183.10%
FCF Yield	-108.24%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a